Medrol /00049601/


Indications and Reactions:

Role Indications Reactions
Secondary
Rheumatoid Arthritis 40.3%
Hypertension 6.5%
Inflammation 6.5%
Pain 6.5%
Idiopathic Thrombocytopenic Purpura 4.8%
Multiple Sclerosis 4.8%
Prophylaxis 4.8%
Arthritis 3.2%
Facial Pain 3.2%
Liver Transplant 3.2%
Arthralgia 1.6%
Bone Pain 1.6%
Hypersensitivity 1.6%
Hyperthyroidism 1.6%
Hypothyroidism 1.6%
Insomnia 1.6%
Joint Swelling 1.6%
Oedema Peripheral 1.6%
Product Used For Unknown Indication 1.6%
Reperfusion Injury 1.6%
Ulcerative Keratitis 15.4%
Asthenia 7.7%
Cerebral Venous Thrombosis 7.7%
Sinusitis 7.7%
Thrombophlebitis 7.7%
Tongue Injury 7.7%
Tonsillar Hypertrophy 7.7%
Transplant Rejection 7.7%
Tuberculin Test Positive 7.7%
Tuberculosis 7.7%
Vaginal Haemorrhage 7.7%
Vomiting 7.7%
Concomitant
Product Used For Unknown Indication 34.6%
Rheumatoid Arthritis 19.1%
Lupus Nephritis 8.8%
Prophylaxis 8.3%
Liver Transplant 4.2%
Renal Transplant 2.9%
Nausea 2.4%
Foetal Exposure During Pregnancy 2.2%
Immunosuppressant Drug Therapy 2.2%
Ischaemia 1.8%
Hypertension 1.7%
Osteoporosis 1.7%
Metastases To Bone 1.5%
Psoriatic Arthropathy 1.5%
Systemic Lupus Erythematosus 1.5%
Pain 1.3%
Chronic Graft Versus Host Disease 1.1%
Pancreas Transplant 1.1%
Premedication 1.1%
Psoriasis 1.1%
No Adverse Event 17.4%
Drug Ineffective 8.7%
Hepatitis C 5.8%
Hepatitis Cholestatic 5.8%
Myocardial Infarction 5.8%
Urinary Tract Infection 5.8%
Progressive Multifocal Leukoencephalopathy 4.3%
Rash 4.3%
Rash Pruritic 4.3%
Sinusitis 4.3%
Vomiting 4.3%
Weight Decreased 4.3%
Weight Increased 4.3%
Cholangitis Chronic 2.9%
Death 2.9%
Oral Herpes 2.9%
Pain In Extremity 2.9%
Periorbital Oedema 2.9%
Psoriasis 2.9%
Pulmonary Embolism 2.9%

Drug Data